Back
Tonix Pharmaceuticals Holding Vs. Acurx Pharmaceuticals Industry Stock Comparison
Sell
24
TNXP
Tonix Pharmaceuticals Holding
Last Price:
0.20
Seasonality Move:
-29.5%
Sell
42
ACXP
Acurx Pharmaceuticals
Last Price:
2.27
Seasonality Move:
10.34%
Sell
24
Tonix Pharmaceuticals Holding (TNXP)
is a Sell
Is Tonix Pharmaceuticals Holding a Buy, Sell or Hold?
- The current Tonix Pharmaceuticals Holding [TNXP] share price is $0.20. The Score for TNXP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- TNXP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Acurx Pharmaceuticals (ACXP)
is a Sell
Is Acurx Pharmaceuticals a Buy, Sell or Hold?
- The current Acurx Pharmaceuticals [ACXP] share price is $2.25. The Score for ACXP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- ACXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TNXP Stock Price Chart
What is Tonix Pharmaceuticals Holding's stock price today?
-
The Tonix Pharmaceuticals Holding share price today is $0.20
The current trend is relatively stagnant and TNXP is experiencing selling pressure, which indicates risk of future bearish movement.
ACXP Stock Price Chart
What is Acurx Pharmaceuticals's stock price today?
-
The Acurx Pharmaceuticals share price today is $2.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
TNXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 54.05 | Buy |
| Chaikin Money Flow: | -4932738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.16 - 0.18) | Buy |
| Bollinger Bands (100): | (0.19 - 0.37) | Sell |
ACXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 56.99 | Buy |
| Chaikin Money Flow: | 20806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.89 - 2.19) | Buy |
| Bollinger Bands (100): | (2.02 - 3.68) | Sell |
TNXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.18 | Buy |
| 20-day SMA: | 0.18 | Buy |
| 50-day SMA: | 0.22 | Sell |
| 200-day SMA: | 0.48 | Sell |
| 8-day EMA: | 0.18 | Buy |
| 20-day EMA: | 0.18 | Buy |
| 50-day EMA: | 0.22 | Sell |
| 200-day EMA: | 1.32 | Sell |
ACXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.11 | Buy |
| 20-day SMA: | 2.09 | Buy |
| 50-day SMA: | 2.15 | Buy |
| 200-day SMA: | 2.9 | Sell |
| 8-day EMA: | 2.15 | Buy |
| 20-day EMA: | 2.1 | Buy |
| 50-day EMA: | 2.26 | Sell |
| 200-day EMA: | 2.82 | Sell |
Tonix Pharmaceuticals Holding Earnings Growth & TNXP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.36 per share, and an increase next year of $0.12 per share.
Acurx Pharmaceuticals Earnings Growth & ACXP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $1.04 per share.
Tonix Pharmaceuticals Holding Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Acurx Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||